Vivos (RDGL) Other Non-Current Assets (2010 - 2025)

Vivos' (RDGL) quarterly Other Non-Current Assets came in at $113703.0 in Q4 2025, up 16895.96% quarter-over-quarter from $669.0 in Q3 2018.

Vivos (RDGL) Other Non-Current Assets (2010 - 2025) Analysis & Trends

Vivos has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $113703.0 for Q4 2025.

Other Non-Current Assets for Q4 2025 came in at $113703.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $113703.0 (changed N/A YoY), and the FY2025 annual result was $113703.0, changed N/A from the prior year.
Other Non-Current Assets came in at $113703.0 for Q4 2025 at Vivos, up from $669.0 in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $113703.0 in Q4 2025 to a low of $113703.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	3.17 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	4.04 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	44.35 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	738.90 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	828.89 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	285.90 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	2.25 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	211.40 Mn
10	Vivos	-	-	-3,105.00	113,703.00

Download Data